Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026)
Lexicon Pharmaceuticals (LXRX) posted quarterly Inventory Average of $278500.0 for Q1 2026, up 28.94% year-over-year from $216000.0 in Q1 2025, and up 26.88% quarter-over-quarter from $219500.0 in Q4 2025.
Lexicon Pharmaceuticals (LXRX) Inventory Average (2017 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has reported Inventory Average for 8 consecutive years, with $278500.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 28.94% year-over-year to $278500.0; the TTM figure through Mar 2026 stood at $278500.0 (up 28.94% YoY), while the FY2025 annual figure was $256000.0, down 16.34% from the prior year.
- Inventory Average grew to $278500.0 in Q1 2026 per LXRX's latest filing, from $219500.0 in the prior quarter.
- Across five years, Inventory Average topped out at $610500.0 in Q3 2024 and bottomed at $163000.0 in Q3 2025.
- Historically, Inventory Average has averaged $337727.3 across 4 years, with a median of $278500.0 in 2026.
- Annual changes were most pronounced in 2024 — Inventory Average surged 140.35% — and 2025, when it sank 73.3%.
- Lexicon Pharmaceuticals' Inventory Average stood at $358500.0 in 2023, then advanced by 20.92% to $433500.0 in 2024, then sank by 49.37% to $219500.0 in 2025, then grew by 26.88% to $278500.0 in 2026.
- Business Quant data shows LXRX's Inventory Average at $278500.0 in Q1 2026, $219500.0 in Q4 2025, and $163000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Lexicon Pharmaceuticals | 1.04 Bn | 846.13 Mn | 653,000.00 | 736,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 736,000.00 |
| Mar 31, 2026 | 278,500.00 |
| Dec 31, 2025 | 219,500.00 |
| Sep 30, 2025 | 163,000.00 |
| Jun 30, 2025 | 184,500.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | 433,500.00 |
| Sep 30, 2024 | 610,500.00 |
| Jun 30, 2024 | 549,500.00 |
| Mar 31, 2024 | 447,500.00 |
| Dec 31, 2023 | 358,500.00 |
| Sep 30, 2023 | 254,000.00 |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 4.20 Mn |
| Dec 31, 2019 | 4.36 Mn |
| Sep 30, 2019 | 4.38 Mn |
| Jun 30, 2019 | 4.44 Mn |
| Mar 31, 2019 | 4.64 Mn |
| Dec 31, 2018 | 4.72 Mn |
| Sep 30, 2018 | 3.45 Mn |